Conditions

Navigating regenerative medicine by anatomy

Patients search body parts, not procedures. Start with where it hurts, understand standard care, then see where cell therapy — and banking for dose — fit honestly.

This guide is anatomy-first: hubs for major joints and the spine, then condition pages for the diagnoses our network actually treats.

Every page educates first. Then you get two exits of equal weight: find a provider who practices medicine, or preserve your cells so dose and donor age stay in your control later.

1

Start with anatomy

Pick the joint or region that matches your search — knee, spine, shoulder, hip, and more as we expand.

2

Read the care ladder

Conservative care, injections, then surgery. Cell therapy sits in that conversation — not as a miracle, as an option your physician may consider.

3

Two exits, no pressure

Find a Forever Labs network provider, or bank your cells so younger biology is available when dose matters.

Browse by anatomy

Tier 1KneeThe knee is the highest-intent anatomy for regenerative queries. Our network treats common knee conditions; Forever Labs supplies banking and (as expansion rolls out) dose.Tier 1SpineSpine care ranges from conservative rehab to injections and surgery. Network physicians evaluate candidates; Forever Labs is not a spinal clinic — we bank cells and support dose when expansion is available.Tier 1ShoulderShoulder regenerative care is often discussed for partial cuff tears and early arthritis. Network physicians decide candidacy; we supply banking infrastructure.Tier 1HipHip OA volume is high; early-stage AVN is lower volume but clinically important. Michigan and network partners treat both where appropriate.Tier 2ElbowEpicondylitis is a Tier 2 hub: meaningful network delivery, solid consumer intent, usually PRP-forward rather than a banking-first story — still listed for completeness.Tier 2Foot & AnkleTier 2 anatomy hub covering plantar fascia and Achilles pathways our network sees in sports and regenerative practices.Tier 2Hand & WristTier 2 hub focused on thumb CMC and related hand arthritis pathways.
Looking for aesthetics / PRP pathways? Visit the separate aesthetics silo →

Why dose and donor age change the picture

The trials that disappoint used unexpanded cells from older donors.

The ones that work used expanded cells at therapeutic dose. Dose is the variable — and dose is what expansion buys you. Potency is what your age buys you.

  1. 1

    Cells work at dose.

    A same-day draw yields a small, uncounted, unexpanded fraction. Expansion turns one draw into many doses.

  2. 2

    Potency is age-dependent, and it is a one-way door.

    Your MSCs at 35 are not your MSCs at 55. Banking is the only mechanism that makes 35-year-old cells available to a 55-year-old.

  3. 3

    Expansion is what makes the bank a supply, not a souvenir.

    Bank once, expand repeatedly, across a treatment course rather than a single shot. Culture expansion for Forever Labs members is rolling out — starting with selected states as our Florida cGMP lab comes online.

  4. 4

    The provider decides what happens next.

    We supply cells; they practice medicine. Forever Labs does not treat conditions — your physician owns the clinical relationship.

Learn how expansion changes the math

Two next steps — equal weight

Forever Labs does not treat conditions. Your physician owns the clinical relationship. We bank cells and, as expansion rolls out, help make dose possible.

Exit oneFind a providerBrowse the Forever Labs physician network for clinics that treat conditions like yours.View providersExit twoPreserve your cellsBank younger MSCs so dose and potency stay available when your physician needs them later.Go to banking